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 2009 Federation of European Biochemical Societies. Published by Elsevier B.V. All rights reserved.1. Introduction biotics [1,3]. One of the major hindrances to the clinical use ofTo protect themselves from invading noxious microorganisms,
multicellular animals and plants produce an array of antimicrobial
peptides (AMPs) as a vital part of the so-called innate immune sys-
tem [1]. To date, several hundred AMPs have been described and
deposited into specialized databases [2]. A simpliﬁed classiﬁcation
envisages three major structural groups of AMPs: (1) linear, with a
strong propensity for a-helix formation; (2) disulﬁde-containing;
(3) linear, non-a-helical, usually proline-, tryptophane-, histidine-
or glycine-rich. Amphipilic a-helical (class 1) peptides represent
one of the major subgroups of AMPs and are rather convenient in
terms of structure–function investigations and production both
via chemical synthesis or gene expression.
Most AMPs target bacterial cell membranes and some have at-
tracted considerable interest as a possible new generation of anti-chemical Societies. Published by E
, effective peptide concentra-
drophobicity potential; MIC,
y).
.many effective AMPs, however, is their ability to damage mamma-
lian cell membranes that leads to high hemolytic and cytotoxic
activity dangerous to the host organism. For some peptides, certain
amino acid substitutions strongly decrease the unwanted hemo-
lytic and cytotoxic activity while leaving the beneﬁcial antimicro-
bial effect intact [4,5]. Several best studied examples include the
cyclic peptide antibiotic gramicidin S [6], disulﬁde-containing b-
hairpin (class 2) protegrins [7] and proline/tryptophane-rich (class
3) indolicidin [8]. Structure–function investigations of these pep-
tides suggested speciﬁc amino acid replacements that ensured
selectivity of their antimicrobial activity. In case of a-helical (class
1) AMPs, impressive efforts have been made to study the effects of
different biophysical parameters including the net charge, chain
length, helicity, hydrophobicity and hydrophobic moment on
activity [3,9–12]. Combinatorial chemistry approaches suggested
that peptide functional properties may not be related to speciﬁc se-
quences or spatial structures [13,14], while careful examination of
naturally occurring AMPs identiﬁed some sequence patterns asso-
ciated with antimicrobial activity [15].
In this paper, we propose a novel approach to rational design of
AMPs devoid of unwanted hemolytic and cytotoxic activity and
thus enhancement of their ability to discriminate between bacte-
rial and eukaryotic cell membranes. The proposed procedure islsevier B.V. All rights reserved.
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zation noted between N-terminal regions in naturally occurring
hemolytic and non-hemolytic peptides and is believed to work
well for most of a-helical AMPs. We use the molecular hydropho-
bicity potential (MHP) approach [16] for bulk analysis of a-helical
AMP sets derived from specialized databases as well as for predic-
tion of single point mutations to eliminate the hemolytic activity of
a selected peptide. We test our assumptions on two recently dis-
covered highly active a-helical AMPs latarcin 2a (Ltc2a) and latar-
cin 5 (Ltc5) from Lachesana tarabaevi spider venom [17]. For Ltc2a,
the three-dimensional structure in detergent micelles is known
and represents the common helix–hinge–helix structural motif
[18]. As for Ltc5, its consideration as a mostly helical peptide is cor-
roborated by secondary structure predictions and circular dichro-
ism spectra measurements [17].Fig. 1. Hydrophobic properties of N-terminal region of AMPs. Normalized distri-
bution of AMP sequences over their F-values. Data for different sets are colored
according to the scale given in the inset. Reference non-hemolytic (magainin 2) and
hemolytic (melittin) AMPs along with Ltc2a and its several mutants are shown with
respect to their F-values.2. Materials and methods
2.1. Analysis of hydrophobic/hydrophilic properties of AMP sequences
Hydrophobic properties of a-helices were calculated and visual-
ized using the molecular hydrophobicity potential (MHP) approach
as described elsewhere [16]. Sequences of a-helical AMPs with low
degree of similarity in their N-terminal regions were selected for
analysis of their hydrophobic/hydrophilic properties from the
APD database [2] and divided into two groups: prominent hemo-
lytic peptides (HEM+, 14 sequences); non-hemolytic peptides
(HEM, 46 sequences). Another AMP database of a-helical pep-
tides [19] was ﬁltered and taken as a reference set (hAMP, 107 se-
quences). For each sequence, the following procedure was applied:
(1) building of the peptide 3D-structure in an ideal helix conforma-
tion; (2) calculation of MHP in each point of the peptide surface
and further interpolation of these data on the plane (2D-MHP
(a,Z) map, where a and Z are rotation angle around the helix axis
and rise along it, respectively); (3) estimation of average values
of hydrophobic (MHP > 0.09) areas (Aphob) and MHP (hmhpi) in
the N-terminal region of the 2D-MHP map (Z < 20 Å); and (4) cal-
culation of scoring value F according to the following equation:
F ¼ ðhmhpi  AphobÞ1=2
The F-values were related to speciﬁc AMP sequences and their
distribution along the AMPs set was schematically presented in
histograms. A similar procedure was carried out for Ltc2a, Ltc5,
their several single-point mutants and peptides with deletions of
the ﬁrst three N-terminal residues. 2D-MHP maps for AMP se-
quences were produced using the PLATINUM program developed
in our laboratory (http://model.nmr.ru/platinum/).
2.2. Peptide synthesis
Peptides were synthesized using Fmoc/t-butyl chemistry as
described in [17]. Ninety-nine percent purity of synthetic peptides
was achieved, veriﬁed by high-performance liquid chromatogra-
phy and matrix-assisted laser desorption/ionization mass
spectrometry.
2.3. Antimicrobial assays
Determination of minimal inhibitory concentration (MIC) val-
ues for the peptides was performed using a twofold microtiter
broth dilution assay as described in [17]. Brieﬂy, bacterial (Bacillus
subtilis VKM B-501, Escherichia coli C600, Staphylococcus aureus
209-P) mid-log phase cultures were diluted in low-salt Luria–
Bertani broth to 105 colony-forming units/ml; 90 ll were mixed
with 10 ll of peptide serial dilutions in 96-well sterile plates. Afterincubation at 37 C for 24 h, growth inhibition was determined by
measuring absorbance at 595 nm.
2.4. Cytotoxicity assays
The hemolytic activity as well as toxicity of the peptides for hu-
man leukocytes and erythroleukemia K562 cells was determined
as described in [20]. Brieﬂy, hemolytic activity was assayed using
fresh capillary human blood. Red blood cells (107 cells/ml) were
incubated with peptides at various concentrations for 3 h at
37 C. Hemoglobin release was monitored by measuring the absor-
bance of the supernatant at 414 nm. Leukocyte-enriched fraction
was obtained as a buffy coat during blood sedimentation. The
K562 cells or leukocytes (106 cells/ml) were incubated with serially
diluted peptides for 3 h (5% CO2, 37 C) and stained with Hoechst
33342 and propidium iodide. The stained cells were examined
with an Axiovert 200 M ﬂuorescence microscope (Carl Zeiss) and
classiﬁed as dead (Hoechst 33342 (+), propidium iodide (+)) or
viable (Hoechst 33342 (+), propidium iodide ()). Cytotoxic
activity of the peptides was characterized by the effective concen-
tration inducing a 50% cell death (EC50).
3. Results and discussion
3.1. Analysis of N-terminal hydrophobic properties along AMP sets
Normalized histograms of F-values for HEM+, HEM, and hAMP
sets (see Section 2) are given in Fig. 1. It is seen that in contrast to
non-hemolytic (HEM) and merely a-helical AMPs, the distribu-
tion for hemolytic (HEM+) peptides is narrow and its maximum
is shifted toward the region of large F-values. This indicates that
hemolytic activity of a-helical AMPs might be correlated with
hydrophobic properties of their N-terminal helices (approximately
13 residues). Namely, a peptide with a prominent hydrophobic N-
terminus (large Aphob and hmhpi values for this region), most prob-
ably, would possess hemolytic activity. Taking into account that
majority of membrane-active peptides prefer interacting with
membranes primarily by their N-terminal regions [21–23] and that
mammalian cell membranes are less polar than bacterial ones
[24,25], this conclusion does not appear too much surprising. Thus,
slight modiﬁcations of hydrophobicity of a-helical AMPs in their
N-terminal parts may produce profound effects on their hemolytic
activity. To test this assumption, we selected two highly active and
hemolytic AMPs, Ltc2a and Ltc5, and predicted several single-point
Fig. 2. Hydrophobic organization of the N-terminal region (20 angstroms in length) of peptide helix for Ltc2a and its single-point mutants. The molecular hydrophobicity
potential (MHP) on the surface of the helices is given in octanol–water partition coefﬁcient logP units. The value of the rotation angle about the axis helix and the rise along it
are plotted on the x and y axes, respectively. Only the hydrophobic areas with MHP > 0.09 are shown. Contour intervals are 0.015. The positions of residue Ca-atoms are
indicated by letters and numbers. Regions of mutations are schematically shown with circles.
Table 1
Amino acid sequences of latarcins 2a and 5 mutants.
Peptide Amino acid sequence F-value
Ltc2a (native) 1GLFGKLIKKFGRKAISYAVKKARGKH26-OH 343.7
Ltc2a_I7Q GLFGKLQKKFGRKAISYAVKKARGKH-OH 278.5
Ltc2a_F10K GLFGKLIKKKGRKAISYAVKKARGKH-OH 261.9
Ltc2a_G11L GLFGKLIKKFLRKAISYAVKKARGKH-OH 405.1
Ltc2a_N-trim 1GKLIKKFGRKAISYAVKKARGKH23-OH 244.5
Ltc5 (native) 1GFFGKMKEYFKKFGASFKRRFANLKKRL28-NH2 327.3
Ltc5_M6R GFFGKRKEYFKKFGASFKRRFANLKKRL-NH2 264.6
Ltc5_N-trim 1GKMKEYFKKFGASFKRRFANLKKRL25-NH2 241.5
A.A. Polyansky et al. / FEBS Letters 583 (2009) 2425–2428 2427mutations along with deletion of several residues in their N-termi-
nal region with further examination of mutant activity proﬁles in a
series of biological tests.Table 2
Biological activity of latarcins 2a and 5 mutants.
Peptide Target cells
E. coli B. subtilis S. aureus
MIC, lM
Ltc2a (native) 3 0.7 1.5
Ltc2a_I7Q 6 1.5 36
Ltc2a_F10K 6 0.7 18
Ltc2a_G11L 3 0.7 1.5
Ltc2a_N-trim 6 0.7 36
Ltc5 (native) 0.7 0.7 0.7
Ltc5_M6R 1.5 0.7 6
Ltc5_N-trim 1.5 0.7 3
a n.t., not tested.3.2. Mutants of Ltc2a andLtc5 with corrected biological activity
According to the 2D-MHP map, Ltc2a possesses a prominent
hydrophobic patch in its N-terminal part (residues 1–10, Fig. 2).
Introduction of polar instead of hydrophobic residues in this region
allows modiﬁcation of size and shape of the patch and thus would
presumably affect the peptide’s activity. We designed two mutants
(Ltc2a_I7Q, Ltc2a_F10K) with proposed lack of hemolytic activity
and also a mutant peptide (Ltc2a_G11L) with an opposite amino
acid replacement, which should be more active on erythrocytes
than the wild-type AMP (Table 1 and Fig. 2). The F-values for Ltc2a
and its mutants as well as for the reference hemolytic (melittin)
and non-hemolytic (magainin 2) peptides are depicted in Fig. 1.
It is seen that the F-value for Ltc2a coincides with the maximum
of the hemolytic distribution (gray bars, Fig. 1), while ‘‘non-hemo-
lytic” and ‘‘hemolytic” mutants of Ltc2a locate in the correspondingErythrocytes Leukocytes K562 cells
EC50, lM
6 18 3
>36 >36 18
>36 >36 18
3 3 0.7
>36 n.t.a >36
12 n.t. 12
>36 n.t. >36
>36 n.t. >36
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performed in a similar manner. Introducing a polar residue in the
N-terminal region of Ltc5 (Ltc5_M6R) decreases the F-value com-
pared to the wild-type peptide (Table 1). To further test the role
of the N-terminal hydrophobic residues, we designed two peptides
with deletion of the ﬁrst three N-terminal residues (Ltc2a_N-trim,
Ltc5_N-trim). In both cases, this removal leads to a signiﬁcant de-
crease of the F-values (Table 1).
The designed mutants were synthesized and their biological
activity was compared to that of the wild-type peptides (Table
2). In Ltc2a_I7Q, Ltc2a_F10K and Ltc5_M6R single-point mutants,
we have seen minor if any decrease in activity against B. subtilis
and E. coli, while the unwanted hemolytic activity and, further-
more, the cytotoxic activity to leukocytes and, to a lesser extent,
erythroleukemia K562 cells, practically disappeared. The effect ob-
served on mammalian cells correlated with a decrease in activity
towards S. aureus known for its ability to modify its cell membrane
into one of a zwitterionic type that resembles eukaryotic mem-
branes [26]. Truncation of three N-terminal residues (Ltc2a_N-
trim, Ltc5_N-trim) produced similar effects on the peptides’ activ-
ity proﬁle (Table 2). This result further emphasizes a signiﬁcant im-
pact of the hydrophobic N-termini of the peptides on their
cytotoxic activity. As predicted, the Ltc2a_G11L mutant exhibited
higher hemolytic and cytotoxic activities, while its antimicrobial
properties were unaffected.
3.3. Conclusion
To summarize, several issues should be outlined. In this study,
we have developed an easy-to-follow approach to ﬁne-tuning
AMPs’ selectivity. We have uncovered differences in organization
of the N-terminal region of a-helical AMPs: those peptides exhib-
iting high hemolytic activity have higher F-values that relate to the
distribution of hydrophobic properties along the molecule (Fig. 1).
We therefore believe that this region serves a trigger of unwanted
hemolytic and other cytotoxic activities of AMPs. Proof of the pro-
posed concept was gained through engineering novel peptides vir-
tually devoid of hemolytic activity out of highly hemolytic
prototypes. The resulting changes of the peptide’s F-value strictly
correlated with its biological activity (Tables 1 and 2). The reported
amino acid substitutions for Ltc2a and Ltc5 follow the more or less
general trend of introducing polar residues into the hydrophobic
side of AMPs’ helices to reduce their hemolytic activity, taken up
after the extensive structure–function studies referenced, but our
approach represents a new valuable tool of quantiﬁcation. We be-
lieve that it may be applied to other a-helical AMPs to adjust their
properties.
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